US Stock MarketDetailed Quotes

GCTK Glucotrack

Watchlist
  • 0.2935
  • +0.0718+32.39%
Close Dec 20 16:00 ET
  • 0.2698
  • -0.0237-8.07%
Post 20:01 ET
4.71MMarket Cap-0.10P/E (TTM)

About Glucotrack Company

GlucoTrack, Inc. designs, develops, and commercializes non-invasive glucose monitoring devices for use by persons suffering from diabetes. The company offers the GlucoTrack model DF-F glucose monitoring device, which utilizes a patented combination of ultrasound, electromagnetic and thermal technologies to obtain glucose measurements in less than one minute via a small sensor that is clipped onto one's earlobe and connected to a small, handheld control and display unit, all without drawing blood or interstitial fluid. It was designed to help people with diabetes and pre-diabetics obtain glucose level readings without the pain. The company was founded by Avner Gal and David Malka in September 2001 and is headquartered in Rutherford, NJ.

Company Profile

SymbolGCTK
Company NameGlucotrack
Listing DateDec 10, 2021
Founded2001
CEOMr. Paul V. Goode, PhD
MarketNASDAQ
Employees6
Fiscal Year Ends12-31
Address301 Route 17 North,Suite 800
CityRutherford
ProvinceNew Jersey
CountryUnited States of America
Zip Code07070
Phone1-201-842-7715

Company Executives

  • Name
  • Position
  • Salary
  • Paul V. Goode, PhD
  • Director, President and Chief Executive Officer
  • 483.24K
  • James P. Thrower
  • Chief Technology Officer
  • 264.11K
  • James S. Cardwell
  • Chief Financial Officer
  • --
  • Drinda Benjamin
  • Vice President, Marketing
  • --
  • Mark Tapsak, PhD
  • Vice President, Technology
  • 176.21K
  • Luis Malave
  • Chairman of the Board
  • 70.00K
  • john Ballantyne
  • Director
  • --
  • Andrew K. Balo
  • Independent Director
  • --
  • Dr. Robert Fischell
  • Independent Director
  • 70.00K
  • Allen E. Danzig
  • Independent Director
  • 70.00K
  • Erin Catherine Carter
  • Independent Director
  • 23.33K
Heat List
US
Overall
Symbol
Price
% Chg

No Data